214 related articles for article (PubMed ID: 27015719)
1. Relationship Between Attention-Deficit/Hyperactivity Disorder Care and Medication Continuity.
Brinkman WB; Baum R; Kelleher KJ; Peugh J; Gardner W; Lichtenstein P; Langberg J; Epstein JN
J Am Acad Child Adolesc Psychiatry; 2016 Apr; 55(4):289-94. PubMed ID: 27015719
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Medication Continuity in Children With ADHD.
Brinkman WB; Sucharew H; Majcher JH; Epstein JN
Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29794230
[TBL] [Abstract][Full Text] [Related]
4. Medication persistence in Turkish children and adolescents with attention-deficit/hyperactivity disorder.
Ayaz M; Ayaz AB; Soylu N; Yüksel S
J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):442-7. PubMed ID: 25010598
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
6. The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child.
DosReis S; Mychailyszyn MP; Evans-Lacko SE; Beltran A; Riley AW; Myers MA
J Child Adolesc Psychopharmacol; 2009 Aug; 19(4):377-83. PubMed ID: 19702489
[TBL] [Abstract][Full Text] [Related]
7. Can parent reports serve as a proxy for teacher ratings in medication management of attention-deficit hyperactivity disorder?
Lavigne JV; Dulcan MK; LeBailly SA; Binns HJ
J Dev Behav Pediatr; 2012 May; 33(4):336-42. PubMed ID: 22371012
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
9. Why do children with ADHD discontinue their medication?
Toomey SL; Sox CM; Rusinak D; Finkelstein JA
Clin Pediatr (Phila); 2012 Aug; 51(8):763-9. PubMed ID: 22584541
[TBL] [Abstract][Full Text] [Related]
10. Do parent perceptions predict continuity of publicly funded care for attention-deficit/hyperactivity disorder?
Zima BT; Bussing R; Tang L; Zhang L
Pediatrics; 2013 Mar; 131 Suppl 1():S50-9. PubMed ID: 23457150
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population.
Hodgkins P; Sasané R; Christensen L; Harley C; Liu F
Curr Med Res Opin; 2011; 27 Suppl 2():53-62. PubMed ID: 21973231
[TBL] [Abstract][Full Text] [Related]
12. Naturalistic Pharmacotherapy Compliance among Pediatric Patients with Attention Deficit/Hyperactivity Disorder: a Study Based on Three-Year Nationwide Data.
Hong M; Kim B; Hwang JW; Bhang SY; Choi HY; Oh IH; Lee YJ; Bahn GH
J Korean Med Sci; 2016 Apr; 31(4):611-6. PubMed ID: 27051247
[TBL] [Abstract][Full Text] [Related]
13. A 36 month naturalistic retrospective study of clinic-treated youth with attention-deficit/hyperactivity disorder.
Hong M; Lee WH; Moon DS; Lee SM; Chung US; Bahn GH
J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):341-6. PubMed ID: 24955936
[TBL] [Abstract][Full Text] [Related]
14. Review of medication adherence in children and adults with ADHD.
Adler LD; Nierenberg AA
Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
[TBL] [Abstract][Full Text] [Related]
15. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study.
Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E
Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527
[TBL] [Abstract][Full Text] [Related]
16. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
[TBL] [Abstract][Full Text] [Related]
17. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study.
Atzori P; Usala T; Carucci S; Danjou F; Zuddas A
J Child Adolesc Psychopharmacol; 2009 Dec; 19(6):673-81. PubMed ID: 20035585
[TBL] [Abstract][Full Text] [Related]
19. Association between quality of life and treatment response in children with attention Deficit Hyperactivity Disorder and their parents.
van der Kolk A; Bouwmans CA; Schawo SJ; Buitelaar JK; van Agthoven M; Hakkaart-van Roijen L
J Ment Health Policy Econ; 2014 Sep; 17(3):119-29. PubMed ID: 25543115
[TBL] [Abstract][Full Text] [Related]
20. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder.
Ibrahim el SR
Hum Psychopharmacol; 2002 Jul; 17(5):225-31. PubMed ID: 12404679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
